VTGN Vistagen Therapeutics, Inc.

NEUTRAL Impact: 3/10 8-K
Horizon weeks Filed Apr 13, 2026 Processed 1mo ago SEC 0001628280-26-024943
8-K context-dependent: Items 5.02
Latest settled — T+20d
VTGN ▲ +11.67% at T+20d
NEUTRAL call ✓ call won +11.67% · α vs SPY +5.37% · entry $0.6000 → $0.6700
Next anchor: T+60d in 28d
Last close $0.5400 (close Jun 8) · -10.00% from $0.6000 entry
Entry anchored
Apr 13, 03:59 PM ET
via Databento tick
T+1d
+1.67%
call +1.67% · α +0.89%
$0.6100
settled 8w ago
T+5d
+1.67%
call +1.67% · α +0.27%
$0.6100
settled 7w ago
T+20d
+11.67%
call +11.67% · α +5.37%
$0.6700
settled 4w ago
T+60d
call — · α —
in 28d

Price Chart

Loading chart...

Executive Summary

Vistagen Therapeutics granted stock options to purchase 75,000 shares each to its CEO and other executive officers as retention awards. The options vest over two years and are intended to incentivize key leadership.

Actionable Insight

Monitor insider exercise behavior and future dilution; assess whether retention efforts correlate with future R&D or funding milestones.

Key Facts

  • Retention stock options granted to CEO Shawn K. Singh and four other executive officers.
  • Each executive received options to purchase 75,000 shares of common stock.
  • Options have an exercise price of $0.5358 per share and vest 25% every six months over two years.
  • Awards were approved by the Compensation Committee on April 7, 2026, under the 2019 Omnibus Equity Incentive Plan.

Financial Impact

Dilutive impact of up to 375,000 new shares if all options are exercised; nominal expense recognition over two years based on fair value.

equity dilutionstock-based compensation

Risk Factors

  • Potential shareholder dilution upon option exercise.
  • Limited cash runway implications if future financing is needed to support ongoing operations.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-024943
Document: 0001628280-26-024943-index-headers.html0001628280-26-024943
Document: 0001628280-26-024943-index.html0001628280-26-024943
Document: 0001628280-26-024943.txt0001628280-26-024943
5 reports for VTGN
Performance horizon
Filters
Rows
Reports for VTGN — sortable, filterable
Type Now
Jun 9, 2026
today
8-K
NEUTRAL ★ 4/10
$0.5388 awaiting T+5awaiting T+5$0.5400 (+0.22%)
May 19, 2026
21d ago
8-K
NEUTRAL ★ 4/10
$0.6400 $0.6300▼ −1.56%▼ −3.36%$0.5400 (−15.62%)
May 12, 2026
28d ago
8-K
NEUTRAL ★ 4/10
$0.6200 $0.6000▼ −3.23%▼ −3.30%$0.5400 (−12.90%)
May 8, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.6700 $0.6000▼ −10.45%▼ −10.36%$0.5400 (−19.40%)
Apr 13, 2026
8w ago
8-K
NEUTRAL ★ 3/10
$0.6000 $0.6100▲ +1.67%▲ +0.27%$0.5400 (−10.00%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 6h 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access